CoreCap Advisors’s West Pharmaceutical WST Stock Holding History

CoreCap Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31.2K	Sell	84 -7	-8%	-$2.47K	﹤0.01%	1617
2026 Q2	$32.7K	Buy	91 +13	+17%	+$3.97K	﹤0.01%	1602
2026 Q1	$19.6K	Buy	78 +1	+1%	+$249	﹤0.01%	1678
2025 Q4	$21.2K	Buy	77 +1	+1%	+$274	﹤0.01%	1657
2025 Q3	$20K	Buy	76 +13	+21%	+$3.16K	﹤0.01%	1673
2025 Q2	$13.8K	Sell	63 -15	-19%	-$3.21K	﹤0.01%	1739
2025 Q1	$17.5K	Buy	78 +13	+20%	+$3.58K	﹤0.01%	1598
2024 Q4	$21.3K	Sell	65 -12	-16%	-$3.78K	﹤0.01%	1511
2024 Q3	$23.1K	Buy	+77	New	+$23.6K	﹤0.01%	1488
2024 Q2	–	Sell	-56	Closed	-$22.2K	–	2611
2024 Q1	$22.2K	Buy	+56	New	+$20.7K	﹤0.01%	1434
2022 Q4	$56.2K	Buy	+239	New	+$56.6K	﹤0.01%	952
2022 Q3	–	Sell	-283	Closed	-$86K	–	2119
2022 Q2	$86K	Buy	+283	New	+$92.1K	0.01%	747
2022 Q1	–	Sell	-1,365	Closed	-$640K	–	2116
2021 Q4	$640K	Buy	+1,365	New	+$588K	0.04%	313

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

CoreCap Advisors's WST Position: Q3 2026 in Review

CoreCap Advisors reduced its West Pharmaceutical (WST) stake by 7.7% in Q3 2026, selling an estimated $2.47K and leaving 84 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

CoreCap Advisors first reported a position in WST in Q4 2021 and has held it in 13 quarters since. The position peaked at $640K in Q4 2021. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

CoreCap Advisors held 84 shares of West Pharmaceutical worth $31.2K as of Q3 2026.
CoreCap Advisors sold 7 West Pharmaceutical shares in Q3 2026, an estimated $2.47K.
West Pharmaceutical made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1617 holding.
CoreCap Advisors first reported a position in West Pharmaceutical in Q4 2021 and has held it in 13 quarters since.
CoreCap Advisors's West Pharmaceutical position peaked at $640K in Q4 2021.
189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.